Chris H.

I run SolisRx, a boutique analytics firm working exclusively with ambulatory infusion centers, home infusion providers, and specialty pharmacies on revenue cycle, referral growth, and intake optimization.

We help infusion and specialty pharmacy leaders find and fix revenue leakage across the full referral-to-cash lifecycle. Over $1M in earnings on Upwork to date, with recent client outcomes including $1.3M per year in authorization gaps detected before claims were denied, $1.6M per year in preventable denials intercepted across eight infusion sites, and $50M in revenue opportunity created through optimized referring provider targeting.

Our most public engagement is FlexCare Infusion Centers, where we built the analytics and operational visibility layer that supported their scale from 20 to 45 sites and their successful acquisition by Optum. Across roughly a dozen multi-site engagements, we have built referral tracking systems, denial intelligence, prescriber profitability models, intake automation, executive dashboards, and M&A diligence packages.

What makes SolisRx different is the combination of three things in one team: business strategy, data and AI execution, and deep infusion industry knowledge. Most healthcare analytics firms have one or two. Few have all three.

My background: BSE in Chemical Engineering from the University of Michigan, MS in Health Data Science from Harvard T.H. Chan School of Public Health, and roughly a decade in healthtech. I presented at NHIA 2026 on AI models for denial management and am presenting at NICA in July on operationalizing GenAI across referral, intake, and RCM.

Who we work best with: independent and PE-backed infusion operators with multi-site complexity, leadership teams making decisions without adequate data, and organizations preparing for growth, new sites, or M&A.

Who we are not the right fit for: single-site practices, hospital outpatient infusion, or anyone looking for a generic Power BI report builder. There are good vendors for those needs and we are not one of them.

If you are leading an infusion or specialty pharmacy organization and want to talk through revenue leakage, referral growth, or what a real analytics infrastructure looks like at your stage, send a note. First conversation is always free.

Chris Hilger
CEO SolisRx